Martingale Asset Management L P Sangamo Therapeutics, Inc Transaction History

Martingale Asset Management L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $100,170 - $149,776	-19,153 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $10,812 - $14,412	1,200 Added 6.68%	19,153 $172,000
Q2 2021 Aug 13, 2021	BUY	$10.17 - $12.64 $182,582 - $226,925	17,953 New	17,953 $214,000
Q2 2020 Aug 10, 2020	SELL	$6.21 - $11.83 $118,300 - $225,361	-19,050 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $160,590 - $281,430	-31,800 Reduced 62.54%	19,050 $121,000
Q4 2019 Feb 10, 2020	BUY	$8.03 - $11.7 $13,650 - $19,890	1,700 Added 3.46%	50,850 $425,000
Q3 2019 Nov 13, 2019	BUY	$9.05 - $12.22 $99,559 - $134,432	11,001 Added 28.84%	49,150 $444,000
Q2 2019 Aug 13, 2019	BUY	$8.75 - $13.03 $333,803 - $497,081	38,149 New	38,149 $0

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.